Tsuyoshi Konishi

Dr. Tsuyoshi Konishi is an associate professor of Colon and Rectal Surgery at the University of Texas M.D. Anderson Cancer Center, in Houston, USA. We again got a chance to hear several of his talks at the COLOSOS conference in Toronto in Oct 2024. 

Dr. Konishi is really helping to bridge the gap between “Eastern” and “Western” approaches to colorectal cancer. In this episode, Dr. Konishi really broke down the sometimes nebulous concept of complete mesocolic excision in right sided colon cancers. We’d really encourage you to head over to our YouTube channel www.youtube.com/@coldsteelsurgery to check out the accompanying video and slides. One of the really enjoyable parts of this conversation was discussing some of the differences between Japanese and North American training – there’s lots we can learn! 

Maybe we should incorporate the Japanese system of having everyone upload their operative video prior to board certification?? What do you think? Send us an email at podcast.cjs@gmail.com.

Bio:

After completion of advanced training in the field of Surgical Oncology and Colorectal Minimally Invasive Surgery at top institutions including the University of Tokyo, Cancer Institute Hospital of the JFCR and Memorial Sloan-Kettering Cancer Center, Dr. Konishi served as an attending colorectal surgeons since 2010, and Head Attending since 2017, at Cancer Institute Hospital of the Japanese Foundation for Cancer Research in Tokyo, Japan. He took a leadership in advancing a minimally invasive surgery program for complex colorectal cancer.

Dr. Konishi’s research interest includes combining multidisciplinary approaches for complex colorectal cancer, including neoadjuvant therapy, extended surgical resection and a minimally invasive surgery. Particularly, he has been taking an international leadership in studying lateral pelvic lymph node dissection for rectal cancer.

Dr. Tsuyoshi Konishi is currently an associate professor of Colon and Rectal Surgery at the University of Texas M.D. Anderson Cancer Center, in Houston, USA. 

Links:

1. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5. doi: 10.1111/j.1463-1318.2008.01735.x. Epub 2009 Nov 5. PMID: 19016817.
2. Konishi T, You YN. Complete Mesocolic Excision and Extent of Lymphadenectomy for the Treatment of Colon Cancer. Surg Oncol Clin N Am. 2022 Apr;31(2):293-306. doi: 10.1016/j.soc.2021.11.009. Epub 2022 Mar 5. PMID: 35351279.
3. RELARC trial: Lu J, Xing J, Zang L, Zhang C, Xu L, Zhang G, He Z, Sun Y, Feng Y, Du X, Hu S, Chi P, Huang Y, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Y, Zhang Z, Zheng M, Su X, Xiao Y; RELARC study group. Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial. J Clin Oncol. 2024 Nov 20;42(33):3957-3966. doi: 10.1200/JCO.24.00393. Epub 2024 Aug 27. PMID: 39190853.
4. Motoyama S, Yamamoto H, Miyata H, Yano M, Yasuda T, Ohira M, Kajiyama Y, Toh Y, Watanabe M, Kakeji Y, Seto Y, Doki Y, Matsubara H. Impact of certification status of the institute and surgeon on short-term outcomes after surgery for thoracic esophageal cancer: evaluation using data on 16,752 patients from the National Clinical Database in Japan. Esophagus. 2020 Jan;17(1):41-49. doi: 10.1007/s10388-019-00694-9. Epub 2019 Oct 3. PMID: 31583502; PMCID: PMC6976551.